Novel insights on use of doxorubicin to treat chemoresistant TNBC by Immunotherapy
Crossref DOI link: https://doi.org/10.17352/2455-8591.000024
Published Online: 2020-07-18
Published Print: 2020-07-18
Update policy: https://doi.org/10.17352/ijicr
Tze-Chen, Hsieh
Joseph M, Wu
Version of Record valid from 2013-11-25
Accepted Manuscript valid from 2015-05-25